UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enantiospecific gas chromatographic–mass spectrometric analysis of urinary methylphenidate: Implications for phenotyping

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008-02, Vol.862 (1), p.140-149

2008

Volltextzugriff (PDF)

A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-10, Vol.858 (1), p.91-95

2007

Volltextzugriff (PDF)

Double-blind donepezil–placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: A pilot study

Schizophrenia research, 2007-07, Vol.93 (1), p.131-135

2007

Volltextzugriff (PDF)

Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007-02, Vol.846 (1), p.351-354

2007

Volltextzugriff (PDF)

Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F2α, a biomarker for in-vivo lipid peroxidation

Journal of pharmacy and pharmacology, 2005-10, Vol.57 (10), p.1365-1369

2005

Volltextzugriff (PDF)

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

The international journal of neuropsychopharmacology, 2004-12, Vol.7 (4), p.415-419

2004

Volltextzugriff (PDF)

Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals

Neuropsychopharmacology (New York, N.Y.), 2004-03, Vol.29 (3), p.551-557

2004

Volltextzugriff (PDF)

Olanzapine penetration into brain is greater in transgenic Abcb I a P-glycoprotein-deficient mice than FVBI (wild-type) animals

Neuropsychopharmacology (New York, N.Y.), 2004, Vol.29 (3), p.551-557

2004

Volltextzugriff (PDF)

Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers

Journal of clinical psychopharmacology, 2003-12, Vol.23 (6), p.576-581

2003

Volltextzugriff (PDF)

Chiral analysis of d- and l-modafinil in human serum: Application to human pharmacokinetic studies

Therapeutic drug monitoring, 2003-04, Vol.25 (2), p.197-202

2003

Volltextzugriff (PDF)

Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment

The international journal of neuropsychopharmacology, 2002-03, Vol.5 (1), p.37-46

2002

Volltextzugriff (PDF)

Clinical pharmacokinetics of sertraline

Clinical pharmacokinetics, 2002, Vol.41 (15), p.1247-1266

2002

Volltextzugriff (PDF)

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

Psychopharmacology bulletin, 2002, Vol.36 (3), p.5

DeVane, C Lindsay

2002

Volltextzugriff (PDF)

In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes

Human psychopharmacology, 2001-10, Vol.16 (7), p.541-544

2001

Volltextzugriff (PDF)

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors

Cellular and molecular neurobiology, 1999-08, Vol.19 (4), p.443-466

DeVane, C L

1999

Volltextzugriff (PDF)

Awareness of potential drug interactions may aid avoidance

Therapeutic drug monitoring, 1997-06, Vol.19 (3), p.366-367

1997

Volltextzugriff (PDF)

The effect of an atypical antipsychotic (risperidone) on temporal lobe and prefrontal cortex activity in schizophrenia

Schizophrenia research, 1997, Vol.24 (1), p.173-173

1997

Volltextzugriff (PDF)

Clinical implications of antidepressant pharmacokinetics and pharmacogenetics

The Annals of pharmacotherapy, 1996-12, Vol.30 (12), p.1471-1480

1996

Volltextzugriff (PDF)

Prescribing attitudes of different physician groups regarding fluoxetine

The Annals of pharmacotherapy, 1993-12, Vol.27 (12), p.1443-1447

1993

Volltextzugriff (PDF)

Pharmacokinetics of the selective serotonin reuptake inhibitors

The journal of clinical psychiatry, 1992-02, Vol.53 Suppl, p.13

DeVane, C L

1992

Volltextzugriff (PDF)

Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain

The Journal of pharmacology and experimental therapeutics, 1990-08, Vol.254 (2), p.584

1990

Volltextzugriff (PDF)

Bupropion in depression. II. The role of metabolites in clinical outcome

Archives of general psychiatry, 1988-02, Vol.45 (2), p.145

1988

Volltextzugriff (PDF)

The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs

Psychopharmacologia, 1986-01, Vol.89 (4), p.404-408

1986

Volltextzugriff (PDF)

The analysis and disposition of imipramine and its active metabolites in man

Psychopharmacologia, 1984-01, Vol.82 (4), p.310-317

1984

Volltextzugriff (PDF)

Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat

Psychopharmacologia, 1984-01, Vol.84 (2), p.225-230

1984

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Enantiospecific gas chromatographic–mass spectrometric analysis of urinary methylphenidate: Implications for phenotyping

A novel HPLC fluorescence method for the quantification of methylphenidate in human plasma

Double-blind donepezil–placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: A pilot study

Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization

Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F2α, a biomarker for in-vivo lipid peroxidation

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals

Olanzapine penetration into brain is greater in transgenic Abcb I a P-glycoprotein-deficient mice than FVBI (wild-type) animals

Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers

Chiral analysis of d- and l-modafinil in human serum: Application to human pharmacokinetic studies

Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment

Clinical pharmacokinetics of sertraline

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes

Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors

Awareness of potential drug interactions may aid avoidance

The effect of an atypical antipsychotic (risperidone) on temporal lobe and prefrontal cortex activity in schizophrenia

Clinical implications of antidepressant pharmacokinetics and pharmacogenetics

Prescribing attitudes of different physician groups regarding fluoxetine

Pharmacokinetics of the selective serotonin reuptake inhibitors

Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain

Bupropion in depression. II. The role of metabolites in clinical outcome

The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs

The analysis and disposition of imipramine and its active metabolites in man

Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat

Suchergebnisse filtern